BANK VONTOBEL/CALL/MODERNA/145/0.1/20.09.24 Stock

Warrant

PQ45V

DE000VM7WHF1

Market Closed - Euronext Paris 12:30:01 2024-05-10 pm EDT
0.61 EUR -22.78% Intraday chart for BANK VONTOBEL/CALL/MODERNA/145/0.1/20.09.24
1 month+11.93%
3 months+86.54%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
24-05-10 0.61 -22.78% 52
24-05-09 0.79 +11.27% 39
24-05-08 0.71 +5.97% 43
24-05-07 0.67 -6.94% 51
24-05-06 0.72 -16.28% 62

Real-time Euronext Paris

Last update May 10, 2024 at 12:30 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MODERNA, INC.
IssuerLogo Issuer Vontobel Vontobel
PQ45V
ISINDE000VM7WHF1
Date issued 2024-01-04
Strike 145 $
Maturity 2024-09-20 (131 Days)
Parity 10 : 1
Emission price 1.17
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.35
Lowest since issue 0.278
Delta0.33x
Omega 5.756
Premium28.76x
Gearing17.63x
Moneyness 0.8124
Difference Strike 27.69 $
Difference Strike %+19.10%
Spread 0.02
Spread %3.17%
Theoretical value 0.6200
Implied Volatility 51.46 %
Total Loss Probability 77.65 %
Intrinsic value 0.000000
Present value 0.6200
Break even 151.68 €
Theta-0.04x
Vega0.02x
Rho0.01x

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
117.3 USD
Average target price
139.4 USD
Spread / Average Target
+18.79%
Consensus
  1. Stock Market
  2. Warrants
  3. PQ45V Warrant
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW